StockData
Schrodinger, Inc. logo

Schrodinger, Inc. (SDGR) stock

SDGRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3044% above fair value
$27.20+1.54 (+6.00%)

Close on Nov 18, 2026Market cap $2.03BP/E –Yield –

Schrodinger net income

Net income is the profit left for shareholders after every expense, interest and tax.

Schrodinger's net income for the twelve months ending Jun 30, 2026 was -$54.34M. For fiscal 2025 it was -$103.27M. The highest annual figure on record is $40.72M in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$103.27M–
FY2024Dec 31, 2024-$187.12M-559.5%
FY2023Dec 31, 2023$40.72M–
FY2022Dec 31, 2022-$149.19M–
FY2021Dec 31, 2021-$100.39M–
FY2020Dec 31, 2020-$24.46M–
FY2019Dec 31, 2019-$24.57M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$5.98M–
Q1 FY2026Mar 31, 2026-$60.03M–
Q4 FY2025Dec 31, 2025$32.51M–
Q3 FY2025Sep 30, 2025-$32.80M–
Q2 FY2025Jun 30, 2025-$43.17M–
Q1 FY2025Mar 31, 2025-$59.81M–
Q4 FY2024Dec 31, 2024-$40.22M–
Q3 FY2024Sep 30, 2024-$38.14M–
Q2 FY2024Jun 30, 2024-$54.05M-1363.4%
Q1 FY2024Mar 31, 2024-$54.72M-142.4%
Q4 FY2023Dec 31, 2023-$30.67M–
Q3 FY2023Sep 30, 2023-$62.02M–
Q2 FY2023Jun 30, 2023$4.28M–
Q1 FY2023Mar 31, 2023$129.14M–
Q4 FY2022Dec 31, 2022-$27.21M–
Q3 FY2022Sep 30, 2022-$39.85M–
Q2 FY2022Jun 30, 2022-$47.69M–
Q1 FY2022Mar 31, 2022-$34.44M–
Q4 FY2021Dec 31, 2021-$30.71M–
Q3 FY2021Sep 30, 2021-$35.01M-1008.8%
Q2 FY2021Jun 30, 2021-$34.64M–
Q1 FY2021Mar 31, 2021-$29.00K–
Q4 FY2020Dec 31, 2020-$11.14M–
Q3 FY2020Sep 30, 2020$3.85M–
Q2 FY2020Jun 30, 2020-$3.35M–
Q1 FY2020Mar 31, 2020-$13.83M–
Q4 FY2019Dec 31, 2019-$6.77M–
Q3 FY2019Sep 30, 2019-$11.51M–
Q2 FY2019Jun 30, 2019-$500.00K–
Q1 FY2019Mar 31, 2019-$5.79M–

More Schrodinger figures

See a number that looks wrong?